lovastatin has been researched along with Abnormal Movements in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezard, E; Guo, JT; Hengerer, B; Ittrich, C; Li, Q; Nadjar, A; Schuster, S | 1 |
1 other study(ies) available for lovastatin and Abnormal Movements
Article | Year |
---|---|
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease.
Topics: Animals; Dyskinesias; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Levodopa; Lovastatin; Male; Parkinson Disease, Secondary; Rats; Rats, Wistar; Severity of Illness Index | 2008 |